Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Blood cholesterol screening influence of fasting state on cholesterol results and management decisions.

Craig SR, Amin RV, Russell DW, Paradise NF.

J Gen Intern Med. 2000 Jun;15(6):395-9.

2.

Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients.

Desmeules S, Arcand-Bossé JF, Bergeron J, Douville P, Agharazii M.

Am J Kidney Dis. 2005 Jun;45(6):1067-72.

PMID:
15957136
3.

Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.

Langsted A, Freiberg JJ, Nordestgaard BG.

Circulation. 2008 Nov 11;118(20):2047-56. doi: 10.1161/CIRCULATIONAHA.108.804146.

5.

Lipoprotein-cholesterol analysis during screening: accuracy and reliability.

Bachorik PS, Cloey TA, Finney CA, Lowry DR, Becker DM.

Ann Intern Med. 1991 May 1;114(9):741-7.

PMID:
2012356
7.

Cross-sectional and longitudinal changes in total and high-density-lipoprotein cholesterol levels over a 20-year period in elderly men: the Honolulu Heart Program.

Abbott RD, Sharp DS, Burchfiel CM, Curb JD, Rodriguez BL, Hakim AA, Yano K.

Ann Epidemiol. 1997 Aug;7(6):417-24. Review.

PMID:
9279451
8.

Effect of aging on the relationship between multiple risk factors and waist circumference.

Iwao S, Iwao N, Muller DC, Elahi D, Shimokata H, Andres R.

J Am Geriatr Soc. 2000 Jul;48(7):788-94.

PMID:
10894318
9.

The effect of fasting status on the determination of low-density and high-density lipoprotein cholesterol.

Wilder LB, Bachorik PS, Finney CA, Moy TF, Becker DM.

Am J Med. 1995 Oct;99(4):374-7.

PMID:
7573092
11.

A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.

Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, Garg N, Sinha N.

Indian Heart J. 2003 May-Jun;55(3):234-40.

PMID:
14560932
12.

Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects.

Schaefer EJ, McNamara JR, Tayler T, Daly JA, Gleason JA, Seman LJ, Ferrari A, Rubenstein JJ.

Am J Cardiol. 2002 Oct 1;90(7):689-96.

PMID:
12356379
13.
14.
15.
16.

A comparison of lipid and lipoprotein measurements in the fasting and nonfasting states in patients with type 2 diabetes.

Dungan KM, Guster T, DeWalt DA, Buse JB.

Curr Med Res Opin. 2007 Nov;23(11):2689-95.

PMID:
17892636
18.
19.

Serum lipid levels for a multicultural population in Auckland, New Zealand: results from the Diabetes Heart and Health Survey (DHAH) 2002-2003.

Gentles D, Metcalf P, Dyall L, Scragg R, Sundborn G, Schaaf D, Black PN, Jackson RT.

N Z Med J. 2007 Nov 9;120(1265):U2800.

PMID:
18264180
20.

A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.

Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW.

Chin Med J (Engl). 2004 Feb;117(2):163-7.

PMID:
14975195

Supplemental Content

Support Center